ISSN: 1449-1907International Journal of Medical Sciences
Global reach, higher impact
Int J Med Sci 2017; 14(6):543-553. doi:10.7150/ijms.18988 This issue Cite
Research Paper
Existence of a Strong Correlation of Biomarkers and miRNA in Females with Metabolic Syndrome and Obesity in a Population of West Virginia
1. Department of Internal Medicine, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA;
2. Department of Surgery, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA;
3. Department of Physiology & Pharmacology, University of Toledo College of Medicine, Toledo OH, USA;
4. Department of Family Medicine, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA;
5. Department of Pharmacology and Medicine, New York Medical College, The Touro College and University System, Valhalla, NY, USA.
* Both authors contributed equally
Abstract
Objectives: Metabolic syndrome causes complications like cardiovascular disease and type 2 diabetes mellitus (T2DM). As metabolic syndrome develops, altered levels of cytokines and microRNAs (miRNA) are measurable in the circulation. We aimed to construct a panel detecting abnormal levels of cytokines and miRNAs in patients at risk for metabolic syndrome. Methods: Participants included 54 patients from a Family Medicine Clinic at Marshall University School of Medicine, in groups of: Control, Obese, and Metabolic Syndrome (MetS). Results: Serum levels of leptin, adiponectin, leptin: adiponectin ratio, IL-6, six miRNAs (320a, 197-3p, 23-3p, 221-3p, 27a-3p, and 130a-3p), were measured. Among the three groups, leptin, and leptin: adiponectin ratio, and IL-6 levels were highest in MetS, and levels in Obese were greater than Control (p>0.05). Adiponectin levels were lower in Obese compared to Control, but lowest in MetS (p<0.05). MiRNAs levels were lowest in MetS, and levels in Obese were lower than Control (p>0.05). Conclusion: Our results support the clinical application of biomarkers in diagnosing early stage MetS, which will enable attenuation of disease progression before onset of irreversible complications. Since West Virginians are high-risk for developing MetS, our biomarker panel could reduce the disease burden on our population.
Keywords: metabolic syndrome, microRNA, serum biomarkers, West Virginia.
Citation styles
